Home
ACTL Immunotherapy
Functional Mechanism
Advantages
Safety
Indications
Protocols
Steps
Patents
Translational Medicine
Treatment & Prevent
Conditions
Case Studies
Cooperative Hospital
Early Detection
Prevention
Nursing & Care
News
Partnership
About Us
Company Introduction
Our Culture
Milestones
Qualification & Honor
Team of Experts
Activities
Jobs
Contact Us
简体
繁体
英文
Coperate News
Coperate News
Industrial News
Policies & Regulations
03-03 2017
Warmly celebrate the fifth anniversary of the establishment of Shenzhen Yishi Kangning Biotechnology Co., Ltd.!
On March 2, Shenzhen Yishi Kangning Biological Technology Co., Ltd. held the fifth annivers...
Details
01-23 2017
Observation results of clinical investigational treatment of patients with advanced metastatic tumors who failed the previous treatment with ACTL technology in 2016
Recently, we reviewed the investigational treatment of a group of patients. All 19 patients starte...
Details
01-01 2017
Ishikoning wishes you a happy new year 2017!
On the occasion of the 2017 New Year's Day holiday, Shenzhen Yishi Kangning Biotechnology C...
Details
11-22 2016
ACTL Technology (Hainan) Center started construction
On the morning of November 18, the ACTL Technology (Hainan) Center officially started const...
Details
09-05 2016
Warmly celebrate Shenzhen Yishi Kangning Biological Technology Co., Ltd. won the "Shenzhen Science and Technology Progress Award"
At 9 am on September 1, the Shenzhen Science and Technology Innovation Conference and the Si...
Details
First
<<
2
3
4
5
6
>>
10
